Biotechnology · Healthcare
Board Member
2025-05-22–present
Board Member
Capricor Therapeutics, Inc. (CAPR)Equibles does not estimate personal net worth.
Paul Auwaerter, M.D. is recorded as Board Member at Capricor Therapeutics, Inc. (CAPR) since May 22, 2025. Capricor Therapeutics, Inc. reported in an 8-K filed May 27, 2025 that Paul Auwaerter, M.D. was appointed director, effective May 22, 2025. Capricor Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Capricor Therapeutics, Inc. includes Linda Marban (CEO and Board Member), Frank Litvack (Chairman and Board Member), Anthony "A.J." Bergmann (CFO) and 7 others.
“Each of Frank Litvack, M.D., Linda Marbán, Ph.D., David B. Musket, George W. Dunbar, Jr., Karimah Es Sabar, Paul Auwaerter, M.D., Philip Gotwals, Ph.D., and Michael Kelliher were elected as directors of the Company to serve until the 2026 annual meeting of stockholders, and until his or her successor is elected, or until his or her earlier death, resignation or removal, as follows:”
2025-05-22–present
Biotechnology · Healthcare
Board Member
2025-05-22–present